Syneos joins with physIQ, InCarda on atrial fibrillation study

Picture of physIQ physIQ : August 30, 2022

Life Sciences Media Mentions

Originally published in Outsourcing Pharma

The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.

Inside an Individual’s Physiological Signature

John Varaklis: January 27, 2023

Originally published in Medical Device & Technology

Corporate Media Mentions

Personalized physiology analytics with Matt Pipke from physIQ

Matt Pipke: January 3, 2023

Originally published in Pixel Scientia Labs

Corporate Podcast

physIQ wants to replace treadmill testing

physIQ: December 16, 2022

Originally published in Crain's Chicago

Media Mentions